154 related articles for article (PubMed ID: 15512813)
1. Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Avilés A; Neri N; Huerta-Guzmán J; Pérez F; Sotelo L
Leuk Lymphoma; 2004 Nov; 45(11):2247-51. PubMed ID: 15512813
[TBL] [Abstract][Full Text] [Related]
2. Interferon alfa 2b as maintenance therapy in poor risk diffuse large B-cell lymphoma in complete remission after intensive CHOP-BLEO regimens.
Avilés A; Cleto S; Huerta-Guzmán J; Neri N
Eur J Haematol; 2001 Feb; 66(2):94-9. PubMed ID: 11168516
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
Aviles A; Duque G; Talavera A; Guzman R
Leuk Lymphoma; 1996 Feb; 20(5-6):495-9. PubMed ID: 8833409
[TBL] [Abstract][Full Text] [Related]
5. High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
Fernández-Ruiz E; Cabrerizo M; Ortega M; Blas C; Llamas P; Santos-Roncero M; Nieto S; Acevedo A; Pérez G; Nicolás C; Fernández-Rañada JM; Arranz R
Clin Cancer Res; 2003 Jul; 9(7):2497-503. PubMed ID: 12855623
[TBL] [Abstract][Full Text] [Related]
6. Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Avilés A; Nambo MJ; Talavera A; Garcia EL; Huerta-Guzman J; Díaz Maqueo JC
Anticancer Drugs; 1997 Nov; 8(10):937-42. PubMed ID: 9436636
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy plus interferon-alpha2b versus chemotherapy in the treatment of follicular lymphoma.
Neri N; Avilés A; Cleto S; Díaz N; Talavera A; García EL; Díaz-Maqueo JC
J Hematother Stem Cell Res; 2001 Oct; 10(5):669-74. PubMed ID: 11672513
[TBL] [Abstract][Full Text] [Related]
8. Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Avilés A; Neri N; Nambo MJ; Huerta-Guzman J; Cleto S
Med Oncol; 2006; 23(2):295-300. PubMed ID: 16720930
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
Avilés A; Fernándezb R; Pérez F; Nambo MJ; Neri N; Talavera A; Castañeda C; González M; Cleto S
Leuk Lymphoma; 2004 Jul; 45(7):1385-9. PubMed ID: 15359637
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
Fisher RI; Dana BW; LeBlanc M; Kjeldsberg C; Forman JD; Unger JM; Balcerzak SP; Gaynor ER; Roy V; Miller T
J Clin Oncol; 2000 May; 18(10):2010-6. PubMed ID: 10811664
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Enschede SH; Porter C; Venugopal P; Gregory SA
Clin Adv Hematol Oncol; 2004 Apr; 2(4):229-33. PubMed ID: 16163187
[TBL] [Abstract][Full Text] [Related]
12. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
[TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy with interferon-alpha 2b, cyclophosphamide, and prednisone in aggressive diffuse large cell lymphoma.
Avilés A; Neri N; Nambo MJ; Castañeda C; Talavera A; Huerta-Guzmán J; Murillo E
Stem Cells Dev; 2004 Apr; 13(2):205-9. PubMed ID: 15186737
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Kim SJ; Kim BS; Choi CW; Seo HY; Seol HR; Sung HJ; Kim IS; Kim CY; Jung KY; Kim JS
Leuk Lymphoma; 2006 Jul; 47(7):1265-73. PubMed ID: 16923556
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
Avilés A; Delgado S; Nambo MJ; Alatriste S; Díaz-Maqueo JC
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):799-803. PubMed ID: 7525515
[TBL] [Abstract][Full Text] [Related]
16. Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Avilés A; Nambo MJ; Neri N; Talavera A; Castañeda C; Murillo E; Cleto S; Huerta-Guzmán J
Med Oncol; 2004; 21(3):269-72. PubMed ID: 15456955
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
Avilés A; Fernández R; Calva A; Neri N; Huerta-Guzmán J; Nambo MJ
Hematology; 2003 Feb; 8(1):7-10. PubMed ID: 12623421
[TBL] [Abstract][Full Text] [Related]
18. A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
Hertzberg M; Matthews JP; Stone JM; Dubosq MC; Grigg A; Ellis D; Benson W; Browett P; Horvath N; Januszewicz H; Abdi E; Green M; Bonaventura A; Marlton P; Cannell P; Wolf M;
Am J Hematol; 2014 May; 89(5):536-41. PubMed ID: 24481640
[TBL] [Abstract][Full Text] [Related]
19. Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691.
Smith SM; Johnson J; Cheson BD; Canellos G; Petroni G; Oken M; Duggan D; Hurd D; Gockerman JP; Parker B; Prchal J; Peterson BA; ;
Leuk Lymphoma; 2009 Oct; 50(10):1606-17. PubMed ID: 19626540
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Solal-Celigny P; Lepage E; Brousse N; Reyes F; Haioun C; Leporrier M; Peuchmaur M; Bosly A; Parlier Y; Brice P
N Engl J Med; 1993 Nov; 329(22):1608-14. PubMed ID: 8232429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]